Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to find optimum dosage of DW-3101 by evaluating efficacy and safety of each dosage group in Korean patients with acute and chronic gastric inflammation.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02386007
Study type Interventional
Source Daewon Pharmaceutical Co., Ltd.
Contact
Status Not yet recruiting
Phase Phase 2